Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Frontiers in Oncology
|
November 17, 2025
Systemic immune-inflammation index: a key biomarker guiding personalized adjuvant chemotherapy in intrahepatic cholangiocarcinoma
Xin Yin, Yanjiang Yin, Wenzhuo Li, et al.
Oncotarget
|
November 19, 2011
ARID2: a new tumor suppressor gene in hepatocellular carcinoma
Hong Zhao, Jian Wang, Yongqing Han, et al.
BMC Cancer
|
December 5, 2021
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China
Yifan Chen, Hongzhi Liu, Jinyu Zhang, et al.
Chinese Medical Journal
|
November 29, 2023
Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition)
Qinghua Meng, Zhengqiang Yang, Zhenyu Zhu, et al.
Cancer Research
|
March 14, 2018
RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca<sup>2+</sup> Uptake and Promotes Colorectal Oncogenesis
Fanxin Zeng, Xiao Chen, Weiyi Cui, et al.
BMC Cancer
|
July 21, 2021
Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study
Hongzhi Liu, Lianku Lin, Ziguo Lin, et al.
Liver Cancer
|
April 21, 2025
Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update
Xinyu Bi, Haitao Zhao, Hong Zhao, et al.
Science Advances
|
November 19, 2025
AI-driven discovery of dual antiaging and anti-AD therapeutics via PROTAC target deconvolution of a super-enhancer-regulated axis
Yuan Sun, Sai Liu, Long Chen, et al.
Cancer Research
|
November 29, 2018
Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma
Li Peng, Binyuan Jiang, Xiaoqing Yuan, et al.
Liver Cancer
|
June 23, 2025
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma
Xinyu Bi, Yinying Lu, Bo Chen, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Frontiers in Oncology
|
November 17, 2025
Systemic immune-inflammation index: a key biomarker guiding personalized adjuvant chemotherapy in intrahepatic cholangiocarcinoma
Xin Yin, Yanjiang Yin, Wenzhuo Li, et al.
Oncotarget
|
November 19, 2011
ARID2: a new tumor suppressor gene in hepatocellular carcinoma
Hong Zhao, Jian Wang, Yongqing Han, et al.
BMC Cancer
|
December 5, 2021
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China
Yifan Chen, Hongzhi Liu, Jinyu Zhang, et al.
Chinese Medical Journal
|
November 29, 2023
Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition)
Qinghua Meng, Zhengqiang Yang, Zhenyu Zhu, et al.
Cancer Research
|
March 14, 2018
RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca<sup>2+</sup> Uptake and Promotes Colorectal Oncogenesis
Fanxin Zeng, Xiao Chen, Weiyi Cui, et al.
BMC Cancer
|
July 21, 2021
Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study
Hongzhi Liu, Lianku Lin, Ziguo Lin, et al.
Liver Cancer
|
April 21, 2025
Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update
Xinyu Bi, Haitao Zhao, Hong Zhao, et al.
Science Advances
|
November 19, 2025
AI-driven discovery of dual antiaging and anti-AD therapeutics via PROTAC target deconvolution of a super-enhancer-regulated axis
Yuan Sun, Sai Liu, Long Chen, et al.
Cancer Research
|
November 29, 2018
Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma
Li Peng, Binyuan Jiang, Xiaoqing Yuan, et al.
Liver Cancer
|
June 23, 2025
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma
Xinyu Bi, Yinying Lu, Bo Chen, et al.
Page
of 14